Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in the 20-Valent Pneumococcal Conjugate Vaccine in the Adult Population in France.

Authors

Euan Dawson, Stéphane Fiévez, Emmanuelle Blanc, Jeffrey Vietri, Mark Rozenbaum, Liem Binh Luong Nguyen

Published in

Open forum infectious diseases. Volume 13. Issue 7. Pages ofag381. Epub Jul 04, 2026.

Abstract

Streptococcus pneumoniae causes invasive pneumococcal disease and pneumonia. This study models the burden of adult pneumococcal disease in France. Over a 5-year period, approximately 630 000 cases and €3.1 billion of costs were attributable to pneumococcus, mostly noninvasive disease, with nearly 80% due to serotypes included in 20-valent pneumococcal conjugate vaccine.

PMID:
42460400
Bibliographic data and abstract were imported from PubMed on 16 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.